Conference Coverage

VIDEO: 'Target: Stroke' program hopes to add hospitals, increase timely treatment


 

SAN DIEGO – The average proportion of ischemic patients who got tissue plasminogen activator within an hour of arriving at participating hospitals increased from 30% before initiation of the Target: Stroke project to 53% afterward. We interviewed Dr. Gregg C. Fonarow about the new phase II of Target: Stroke, launched at the International Stroke Conference , which aims for timely door-to-needle treatment in 75% of stroke patients.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

Stroke outcomes poorer when criteria precluded endovascular therapy
MDedge Emergency Medicine
Policy statement outlines components of successful stroke care
MDedge Emergency Medicine
Blood pressure control tied to decline in stroke mortality over past 50 years
MDedge Emergency Medicine
FDA panel rejects rivaroxaban again for acute coronary syndrome
MDedge Emergency Medicine
New tools for stroke prediction in atrial fibrillation
MDedge Emergency Medicine
Video: Positive trends for outcomes in uric acid stroke trial gives optimism
MDedge Emergency Medicine
Video: Study hints uric acid reduces acute stroke symptoms
MDedge Emergency Medicine
Uric acid for stroke trials to continue
MDedge Emergency Medicine
VIDEO: Highlights of the Annual Stroke Conference
MDedge Emergency Medicine
'Target: Stroke' program gets most patients timely treatment
MDedge Emergency Medicine

Related Articles